Skip to content
healthcare.dev

oxybutynin

NDC 67296-2335, oxybutynin, tablet, film coated, extended release, from Redpharm Drug.

Product NDC
67296-2335
Status
Listed
Labeler
Redpharm Drug
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202332
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67296-2335 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
67296-2335-36729623350330 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67296-2335-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5b432aae-8a9d-8846-e063-6394a90a3b0d

Use it

Look up 67296-2335 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67296-2335 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67296-2335. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.